CLASS III ONGOING Drug recall · Reported 7 Jan 2026 · FDA Enforcement Report

traZODONE Hydrochloride Tablets, USP, 100mg recalled

Zydus Pharmaceuticals (USA) is recalling traZODONE Hydrochloride Tablets, USP, 100mg, distributed nationwide in the US. The recall was initiated on 19 Dec 2025 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # EA00237A, Exp Date: 04/30/2027
NDC68382-609, 68382-805, 68382-806, 68382-807, 68382-808, 68382-610
UPC0368382808011
Quantity recalled2,136 1000-count bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0247-2026
FDA event ID
98184
Recalling firm
Zydus Pharmaceuticals (USA), Pennington, NJ
Manufacturer
Zydus Pharmaceuticals USA Inc.
Classification
Class III
Status
Ongoing
Recall initiated
19 Dec 2025
FDA classified
31 Dec 2025
Reported
7 Jan 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Drug class
Antidepressants

Timeline

19 Dec 2025Recall initiated by company
31 Dec 2025Classified by FDA+12 days
7 Jan 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.

Product as listed by the FDA

traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Is traZODONE Hydrochloride Tablets, USP, 100mg recalled?

Yes. Zydus Pharmaceuticals (USA) recalled traZODONE Hydrochloride Tablets, USP, 100mg on 19 Dec 2025. The recall is Class III and its status is Ongoing. Recall number D-0247-2026.

Why was it recalled?

Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.

Which lots are affected?

Lot # EA00237A, Exp Date: 04/30/2027

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Zydus Pharmaceuticals (USA)

All 95

Other Trazodone recalls

All 8